Shares of Alkem Labortories fell in opening trade on February 21 after a large deal worth Rs 300 crore took place on the exchanges. As much as 6.41 lakh shares of the drugmaker were sold ...

According to the block deal data available on the National Stock Exchange (NSE), SBI Mutual Fund acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories. The shares ...

Samprada & Nanhamati Singh Family Trust sold 6,41,712 shares (0.54 percent stake) of Alkem Laboratories Ltd in a bulk deal at a Rs 4,680 per share. The total value of the transaction was around Rs ...

Alkem Labs announced two strategic acquisitions totalling nearly Rs 290 crore to cement its position in the domestic market. Alkem has signed a binding term sheet to acquire 100% stake of Adroit ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction. According to the block deal data available on the ...

SBI Mutual Fund bought additional shares of Alkem Laboratories for Rs 300 crore, increasing its stake to 2.7%. The shares, totaling 6.41 lakh, were acquired at Rs 4,680 each. This transaction saw the ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction. According to the block deal data available on the ...

New Delhi: SBI Mutual Fund has acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories for Rs 300 crore through an open market transaction. The shares were picked ...